Response to cardiac resynchronization therapy across chronic kidney disease stages.

[1]  P. Martens,et al.  Effect of multidisciplinary cardiac rehabilitation on the response to cardiac resynchronization therapy , 2018, Cardiovascular therapeutics.

[2]  P. Cunha,et al.  Response and outcomes of cardiac resynchronization therapy in patients with renal dysfunction , 2018, Journal of Interventional Cardiac Electrophysiology.

[3]  I. V. Van Gelder,et al.  Refining success of cardiac resynchronization therapy using a simple score predicting the amount of reverse ventricular remodelling: results from the Markers and Response to CRT (MARC) study , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[4]  F. Verbrugge,et al.  Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions. , 2017, The American journal of cardiology.

[5]  F. Verbrugge,et al.  Feasibility and Association of Neurohumoral Blocker Up-titration After Cardiac Resynchronization Therapy. , 2017, Journal of cardiac failure.

[6]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[7]  W. Paulus,et al.  Connecting heart failure with preserved ejection fraction and renal dysfunction: the role of endothelial dysfunction and inflammation , 2016, European journal of heart failure.

[8]  Jagmeet P. Singh,et al.  Comparative Effectiveness of CRT-D Versus Defibrillator Alone in HF Patients With Moderate-to-Severe Chronic Kidney Disease. , 2015, Journal of the American College of Cardiology.

[9]  W. Tang,et al.  Reverse Remodeling and Prognosis Following Kidney Transplantation in Contemporary Patients With Cardiac Dysfunction. , 2015, Journal of the American College of Cardiology.

[10]  Jeroen J. Bax,et al.  Cardiac Resynchronization Therapy in CKD Stage 4 Patients. , 2015, Clinical journal of the American Society of Nephrology : CJASN.

[11]  M. Picard,et al.  Renal Response in Patients with Chronic Kidney Disease Predicts Outcome Following Cardiac Resynchronization Therapy , 2015, Pacing and clinical electrophysiology : PACE.

[12]  A. Auricchio,et al.  20 years of cardiac resynchronization therapy. , 2014, Journal of the American College of Cardiology.

[13]  G. Hindricks,et al.  Treatment with higher dosages of heart failure medication is associated with improved outcome following cardiac resynchronization therapy. , 2014, European heart journal.

[14]  J. McMurray,et al.  Current evidence on treatment of patients with chronic systolic heart failure and renal insufficiency: practical considerations from published data. , 2014, Journal of the American College of Cardiology.

[15]  C. O'connor,et al.  Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis. , 2014, European heart journal.

[16]  P. Vandervoort,et al.  Revisiting diastolic filling time as mechanistic insight for response to cardiac resynchronization therapy. , 2013, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[17]  Jagmeet P. Singh,et al.  Usefulness and consequences of cardiac resynchronization therapy in dialysis-dependent patients with heart failure. , 2013, The American journal of cardiology.

[18]  G. Thomas,et al.  Cardiac resynchronization therapy in CKD: a systematic review. , 2013, Clinical journal of the American Society of Nephrology : CJASN.

[19]  M. Gold,et al.  Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study , 2012, European journal of heart failure.

[20]  Jeroen J. Bax,et al.  Impaired renal function is associated with echocardiographic nonresponse and poor prognosis after cardiac resynchronization therapy. , 2011, Journal of the American College of Cardiology.

[21]  S. Saba,et al.  Response to Cardiac Resynchronization Therapy in Patients with Heart Failure and Renal Insufficiency , 2010, Pacing and clinical electrophysiology : PACE.

[22]  G. Navis,et al.  Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease. , 2009, Journal of the American College of Cardiology.

[23]  Gary S Francis,et al.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2009, Journal of the American College of Cardiology.

[24]  R. Starling,et al.  Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function? , 2008, Journal of the American College of Cardiology.

[25]  R. Schrier.  Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor? , 2006, Journal of the American College of Cardiology.

[26]  G. Eknoyan,et al.  Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). , 2005, Kidney international.

[27]  J. Daubert,et al.  The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.

[28]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[29]  D. DeMets,et al.  Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. , 2004, The New England journal of medicine.

[30]  D. Delurgio,et al.  Cardiac resynchronization in chronic heart failure. , 2002, The New England journal of medicine.

[31]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[32]  W. Tang,et al.  Impact of Iron Deficiency on Response to and Remodeling After Cardiac Resynchronization Therapy. , 2017, The American journal of cardiology.

[33]  Jeroen J. Bax,et al.  2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). , 2013, European heart journal.